Citation: | TONG Xinyong, LI Limin. Preparation of levobupivacaine hydrochloride sustained-release in-situ gel injection and its pharmacokinetic and pharmacodynamic studies in animals[J]. Journal of China Pharmaceutical University, 2015, 46(2): 209-213. DOI: 10.11665/j.issn.1000-5048.20150212 |
[1] |
Andrea C, Marta P. Bupivacaine, levobupivacaine and ropivacaine:are they clinically different[J]?Best Pract Res Clin Anaesthesiol,2005,19(2):247-268.
|
[2] |
Bajwa SJ,Kaur J.Clinical profile of levobupivacaine in regional anesthesia:a systematic review[J].J Anaesthesiol Clin Pharmacol,2013,29(4):530-539.
|
[3] |
Tong YC,Kaye AD,Urman RD.Liposomal bupivacaine and clinical outcomes[J].Best Pract Res Clin Anaesthesiol,2014,28(1):15-27.
|
[4] |
McAlvin JB,Reznor G,Shankarappa SA,et al.Local toxicity from local anesthetic polymeric microparticles[J].Anesth Analg,2013,116(4):794-803.
|
[5] |
Zeng HL,Shi Z,Fu XD.Progress in clinical application of the bupivacaine liposome injectable suspension Exparel[J].ChinJ New Drugs(中国新药杂志),2014,23(14):1654-1658.
|
[6] |
Judy S,Michael R.Sustained-Release Injectable Products(可注射缓释制剂)[M].Beijing:Chemical Industry Press,2005:136-137,152.
|
[7] |
Skolnik A,Gan TJ.New formulations of bupivacaine for the treatment of postoperative pain:liposomal bupivacaine and SABER-Bupivacaine[J].Expert Opin Pharmacother,2014,15(11):1535-1542.
|
[8] |
Qi N, Tang X, Lin X, et al. Sterilization stability of vesicular phospholipid gels loaded with cytarabine for brain implant[J].Int J Pharm,2012,427(2):234-241.
|
[9] |
Zhang RZ, Deng YJ, Sun WP. Research progressin vesicular phospholipid gel[J].Chin J Pharm(中国药剂学杂志),2008,6(4):214-218.
|